Abstract. The aim of the present study was to investigate the cytotoxicity of natural killer (NK) cells to CaSki cells following knockdown of the E7 protein of the human papillomavirus type 16 (HPV16E7). Recombinant adenovirus-short hairpin-E7 protein of the human panillomavirus type 16 (Ad-sh-
Introduction
Persistent infection with high-risk human papillomavirus (HPV) is the major cause of cervical cancer. The transforming proteins E6 and E7 encoded by high-risk HPV are able to interact with the intracellular tumor suppressor protein p53 and the retinoblastoma protein (pRb), respectively, leading to cell immortalization (1) . Surface molecules of virus-infected cells have frequently been observed to transform in order to evade recognition by immune cells. Major histocompatibility complex-I (MHC-I) is one of these molecules and has an important role in tumor immune responses. MHC-I expression levels have been observed to decrease in cervical cancer cells and the functional components such as transporter associated with antigen processing 1 (TAP1) are frequently deactivated, enabling tumor cells to evade immune surveillance (1) . Natural killer (NK) cells are highly significant effector cells of the innate immune response and are able to kill virus-infected or transformed cells. NK cells are derived from cluster of differentiation molecule 34 (CD34) + progenitor cells which account for 1-32% of human peripheral blood lymphocytes (2) (3) (4) . These large granular lymphocytes express the cluster of differentiation molecule 56 (CD56); however, not the cluster of differentiation molecule 3 (CD3) or T-cell receptor molecule (TCR). Their functions are regulated through balanced activity of inhibitory receptors, including killer-cell immunoglobulin-like receptors (KIR) and activation receptors, including the natural killer cell-related proteins 30, 44 and 46 (NKp30, NKp44 and NKp46). NK cells have prospective applications in adoptive immunotherapy of tumors as they are able to lyse target cells directly without sensitization (3, 4) .
The present study aimed to investigate MHC-I expression in CaSki cells infected with the recombinant adenovirus Ad-sh-HPV16E7 as well as to assess the cytotoxicity of NK cells isolated from healthy human peripheral blood to cervical cancer cells. The CaSki cells were infected with the recombinant adenovirus at a multiple of infection (MOI) of 10 following titration. The expression of MHI-I was assessed using flow cytometry with ad-mock adenovirus as a control.
Materials and methods

Construction
Expression of HPV16E7. The expression of HPV16E7 was assessed using western blot analysis. A phosphate-buffered saline (PBS)-treated group and adenovirus-enhanced green fluorescence protein (Ad-EGFP)-infected group were used as negative controls. A HPV16E7-siRNA transfected with a liposome group was used as the positive control and the Ad-shRNA-HPV16E7 group was the experimental group. HPV16E7-siRNA was designed by our laboratory and has been proven to inhibit HPV16E7 expression effectively. CaSki cells were collected 72 h post-infection in all the groups, and subsequently lysed with radio-immunoprecipitation assay (RIPA) reagent [0.3% NP40, 1 mM EDTA, 50 mM Tris-Cl (pH 7.4), 2 mM EGTA, 1% Triton X-100, 150 mM NaCl, 25 mM NaF, 1 mM Na 3 VO 3 , 10 µg/ml benzene methylation sulfonic acid oriented fluorine] on ice for 30 min. Cells were then centrifuged at 4˚C at 12,000 x g for 15 min. The supernatant was used for western blot analysis. The first antibody was anti-HPV16E7 (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), while the secondary antibody was sheep anti-mouse immune globulin (Chemicon, Temecula, CA, USA).
MHC-I expression in CaSki cells.
Three days following infection, five tubes of CaSki cells were harvested with 10 5 cells/tube. Mouse anti-human monoclonal antibody labeled with fluorescein isothiocyanate (FITC) was added into every tube. The isotype control was mouse immunoglobulin G (IgG). Cells were incubated for 30 min, washed once with PBS and added into 500 µl PBS prior to analysis by flow cytometry.
NK cell isolation. Cells collected from peripheral blood mononuclear cells (PBMCs) using immunomagnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) were irradiated with 25 Gy in order to prevent them from overgrowth. The NK cells (1x10 5 /ml) purified by immunomagnetic beads were cultured in a 24-well plate at a dilution of 1:20. AIM-V medium containing 5% human serum (Sigma-Aldrich, St. Louis, MO, USA) and 500 IU/ml recombinant human interleukin 2 (rhIL-2) in it. During the first five days, anti-cluster of differentiation 3 (CD3) monoclonal antibody (10 ng/ml) was added into the medium. The medium with anti-CD3 was replaced with IL-2 in fresh medium. The amplified cells were analyzed using flow cytometry. The number of cells was directly calculated following trypan blue staining.
In vitro cytotoxicity assays. Cytotoxicity of the NK cells to CaSki cells was assessed using the lactate dehydrogenase (LDH) release assay. Amplified NK and CaSki cells were co-cultured at 37˚C for 4 h at ratios of 1:10, 1:30, 1:50. Culture medium (100 µl) excluding effector cells was added via the natural release hole, followed by the addition of 100 µl 1% nonyl phenoxypolyethoxyethanol (NP40) via the maximum release hole. Each experiment was performed in three replicates. The specific cytotoxicity was calculated as: Cytotoxicity (%) = [(OD experimental group-OD total spontaneous release)/(OD maximum release group-OD total spontaneous release)] x100%, with OD being the optical density.
Statistical analysis. SPSS 17.0 statistical software (SPSS, Inc., Chicago, IL, USA) was used for data analysis. Two independent samples were compared using the t-test. Differences were considered statistically significant for P<0.05.
Results
Construction of the adenovirus vector.
The PCR results for the virus were collected at 72 h following transfection with Ad-shRNA-HPV16E7 (Fig. 1) . PCR bands were significant on the 3rd and 4th lanes at 287 bp, indicating that pAd-shRNA-HPV16E7 and pAd-EGFP were constructed successfully. The CaSki cells were infected with Ad-EGFP and the infection was confirmed following 48 h of incubation.
Assessment of HPV16E7 protein suppression using western blot analysis. The expression of HPV16E7 was inhibited in the HPV16E7-siRNA and Ad-shRNA-HPV16E7 groups compared with the PBS control group. There was significant statistical difference between the Ad-shRNA-HPV16E7 and PBS groups (P<0.01) (Fig. 2A) . The expression levels of HPV16E7 were statistically increased in the HPV16E7-siRNA group compared with those in the Ad-shRNA-HPV16E7 group (P<0.05) (Fig. 2B) .
MHC-I on CaSki cells assessed using flow cytometry.
The amount of MHC-I cell-surface molecules was increased by almost 55% in CaSki cells infected with Ad-sh-HPV16E7 compared with isotype antibody-infected cells, while there was almost no effect in the PBS-treated controls. The number of MHC-I molecules was significantly increased following HPV16E7 knockdown by Ad-sh-HPV16E7 (P<0.01). This indicates that HPV16 infection may lead to decreased expression of MHC-I (Fig. 3) .
Amplification of NK cells. Immunomagnetic separation was used to purify CD56
+ lymphocytes without the effect of CD3 + T cells. NK cell amplification was stimulated by recombinant IL-2 and anti-CD3 monoclonal antibodies. The final purity of the NK cells was 95.3% according to flow cytometric analysis, indicating that relatively high levels of purity of NK cells are able to be achieved by this method; however, a small number of T cells may still be present (Fig. 4) .
Cytotoxicity of the NK cells to CaSki cells. Infection of CaSki cells with the recombinant adenovirus Ad-sh-HPV16E7
resulted in increases in the amounts of MHC-I which may increase the susceptibility to NK cells. The cytotoxicity in this group was significantly higher than that in the group infected with adenovirus Ad-EGFP at 1:50, 1:10 and 1:30. The effect was was more significant at higher ratios (Fig. 5 ).
Discussion
Infection with high-risk HPV16 accounts for 50-70% of all incidences of cervical cancer, with HPV16E7 being among the main pathogenic genes. Therefore, the HPV16E7 gene has an important role in the pathogenesis of cervical cancer and other diseases associated with HPV infection (1) . In the present study, MHC-I expression in CaSki cells increased following HPV16E7 silencing by recombinant Ad-sh-HPV16E7, which indicated that the HPV16E7 protein reduced MHC-I The LDH release assay was used to demonstrate that the cytotoxicity of NK cells to CaSki cells was lower than to Ad-sh-HPV16E7-infected CaSki cells, indicating that NK cells are able to recognize the changes in MHC-I expression in the target cells. Inhibition of the expression of E7 increased MHC-I levels in CaSki cells by 55%, similar to a study reporting the increase of MHC-I levels by 30% induced by adenovirus early region 1A (AdE1A) suppression with an antisense oligonucleotide (9) . Another study reported that reduced levels of MHC-I on an adenovirus type 12 (Ad12)-transformed cell surface were related to the susceptibility to NK cells (3). These results suggested that the expression of MHC-I was inhibited by HPV to evade host-immune cell recognition; however, this also increased the cytotoxic activity of NK cells to CaSki cells.
Besides MHC-I, NK cells are regulated by several molecules expressed on the target cells. The activity of NK cells is able to be inhibited by the non-classical MHC-I molecule HLA class 1 histocompatibility antigen, α chain E (HLA-E) through interactions of the heterodimer CD94/NK gene 2A (NKG2A) (10) . However, the expression levels of HLA-E in CaSki cells are extremely low (11, 12) . Whether the HLA-E expression is modified by siRNA-mediated E7 knockdown requires further study.
In conclusion, the inhibition of antigen presentation and decrease in the amounts of MHC-I are mediated by E7 through a variety of mechanisms, enabling viruses to escape immune responses in the replication process (13) (14) (15) . This indicates that amplification of NK cells in vitro may be used for immunotherapy of cervical cancer.
